Johnson & Johnson is learnt to be in advanced discussions to buy US cancer drugmaker Pharmacyclics, in a potential blockbuster deal that would mark the latest chapter in the ongoing consolidation of the global healthcare industry.

Financial News

Johnson & Johnson

Deutsche Bank’s UK MD numbers slide for the first time in four years

HSBC plans to increase staff surveillance as it moves to new London HQ

Why Deutsche Bank’s former FX chief is reinventing himself as an opera composer

Milbank hires private equity M&A rising star in Germany

https://images.fnlondon.com/im-43406752?size=1.5

Coutts hires ex-JPMorgan banker James Todd as next private client boss

https://images.fnlondon.com/im-95923804?size=1.42

Todd replaces Camilla Stowell who left the NatWest-owned wealth in January

Senior GIC private equity lawyer joins Dechert in London

https://images.fnlondon.com/im-14432569?size=1.5

US law firm hires private equity specialist from key client

Junior bankers at Robert W. Baird say such long hours weren’t unusual for industrials team.

110-Hour Workweeks Drove Young Bankers at a Boutique Firm to the Brink

Once an heir apparent for Larry Fink, Wiedman now tops the list of potential successors to PNC chief Bill Demchak.

PNC Names Former BlackRock Star Mark Wiedman as President

The European Union has a plan to counteract the swathe of tariffs U.S. President Trump is planning to impose on foreign goods, European Commission President Ursula von der Leyen said.

EU Has Plan to Retaliate on U.S. Tariffs, Von der Leyen Says

The Japanese investment firm is entwining its fortunes with a company that expects to lose billions of dollars for years to come, in the hope that it will emerge as the leader in AI.

How Is SoftBank Funding Its Mega Investment in OpenAI? A Lot of Debt

The BlackRock CEO says he wants individuals to have better access to the menu of private and illiquid investments that have long been core holdings of pensions, endowments and other institutions.

Larry Fink Says Regular Americans Need Private Assets Too

KOnTotJMkZarR8tulzuR/VzL7SkGahFEk/YYosb+TjqaAEWmukGhEhYUWjxP2r4pA0xDXQQ1ZU69yYeE+MoFuX+vqkkIDnWxEFWCQrptVHI71qIKj23MEQhbGt+MvxhglqJM6Tbdkbt5DG70reIjRIySOHnGkQqS3hCbGaaGzAhaWF1ZrHPzgON3ryj914m8HYMiWjqSmon4AmWXRfZyuQDu+8UJ+2bHrJB4RBvIB+nLDAxDZhAOfK2r//hnammGznaL86RJZ4GNcvKKIUFCHbN1v9DoLnCDHxvZO6lXagr5vaB/uCqqJMHQD29K

https://www.wsj.com?type=allesseh_content_full_list

https://ace.fnlondon.com/client

MY ACCOUNT

ABOUT

SECTIONS

unbolded

J&J closes in on Pharmacyclics takeover